Picture of Ceapro logo

CZO Ceapro Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Momentum

Relative Strength (%)
1m+3.39%
3m+42.47%
6m-40.56%
1yr-59.92%
Volume Change (%)
10d/3m-65.99%
Price vs... (%)
52w High-60.94%
50d MA+15.58%
200d MA-19.28%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-12.07%
Return on Equity-8.74%
Operating Margin-34.49%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Ceapro EPS forecast chart

Profile Summary

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
April 1st, 2016
Public Since
November 18th, 1987
No. of Employees
12
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
ca flag iconTSX Venture Exchange
Shares in Issue
78,293,177

CZO Share Price Performance

Upcoming Events for CZO

Q1 2024 Ceapro Inc Earnings Release

Ceapro Inc Annual Shareholders Meeting

Q2 2024 Ceapro Inc Earnings Release

Similar to CZO

Picture of Arch Biopartners logo

Arch Biopartners

ca flag iconTSX Venture Exchange

Picture of biOasis Technologies logo

biOasis Technologies

ca flag iconTSX Venture Exchange

Picture of Covalon Technologies logo

Covalon Technologies

ca flag iconTSX Venture Exchange

Picture of Hemostemix logo

Hemostemix

ca flag iconTSX Venture Exchange

Picture of Innovotech logo

Innovotech

ca flag iconTSX Venture Exchange

FAQ